111, Inc. YI

Company Overview

111, Inc. is a China-based digital healthcare company focused on the online distribution of pharmaceutical products and healthcare services. The company operates in the digital healthcare, online pharmacy, and healthcare supply chain services industries, providing both business-to-consumer (B2C) and business-to-business (B2B) solutions. Its core activities center on enabling patients, pharmacies, and healthcare providers to access prescription and over-the-counter medicines through integrated online platforms.

The company’s primary revenue drivers historically include online pharmaceutical retailing, wholesale pharmaceutical distribution, and value-added services such as SaaS tools for pharmacies. 111, Inc. is best known for operating 1 Drugstore (1药网), one of China’s early online pharmacy platforms, which supports direct-to-consumer sales and prescription fulfillment. Founded in 2010, the company evolved from an online pharmacy startup into a broader digital healthcare platform and completed an initial public offering on NASDAQ in 2018. Public disclosures indicate that the company has faced regulatory, pricing, and profitability pressures in recent years, with aspects of its public listing status changing after 2022; details vary across public sources.